skip to content

Cambridge Academy of Therapeutic Sciences

AI system may accelerate search for cancer discoveries

29 November 2018

AI system may accelerate search for cancer discoveries Searching through the mountains of published cancer research could be made easier for scientists, thanks to a new AI system. The system, called LION LBD and developed by computer scientists and cancer researchers at the University of Cambridge, has been designed to...

Read more

Microsoft to support AI research at Cambridge University

5 November 2018

The University of Cambridge is teaming up with Microsoft to tackle the problem of 'brain drain' in AI and machine learning research. The software giant will help increase AI research capacity and capability at Cambridge by supporting visiting researchers, postdoctoral researchers, PhD students and interns from the UK, EU...

Read more


3D ‘organ on a chip’ could accelerate search for new disease treatments

31 October 2018

Researchers have developed a three-dimensional ‘organ on a chip’ which enables real-time continuous monitoring of cells, and could be used to develop new treatments for disease while reducing the number of animals used in research. Two-dimensional cell models have served the scientific community well, but we now need to...

Read more

Many cases of dementia may arise from non-inherited DNA ‘spelling mistakes’

18 October 2018

Many cases of dementia may arise from non-inherited DNA ‘spelling mistakes’ Only a small proportion of cases of dementia are thought to be inherited – the cause of the vast majority is unknown. Now, in a study published today in the journal Nature Communications , a team of scientists led by researchers at the University...

Read more


Targeting hard-to-treat cancers

17 October 2018

Cambridge leads a £10 million interdisciplinary collaboration to target the most challenging of cancers. We are going to pierce through the body’s natural barriers and deliver anti-cancer drugs to the heart of the tumour. George Malliaras While the survival rate for most cancers has doubled over the past 40 years, some...

Read more

Mitochondrial diseases could be treated with gene therapy, study suggests

27 September 2018

Mitochondrial diseases could be treated with gene therapy, study suggests Researchers have developed a genome-editing tool for the potential treatment of mitochondrial diseases: serious and often fatal conditions which affect 1 in 5,000 people. One idea for treating these devastating diseases is to reduce the amount of...

Read more


Professor Sir Greg Winter wins the 2018 Nobel Prize in Chemistry

3 October 2018

Professor Sir Greg Winter, of the University of Cambridge, has been jointly awarded the 2018 Nobel Prize in Chemistry along with Frances Arnold and George Smith for his pioneering work in using phage display for the directed evolution of antibodies, with the aim of producing new pharmaceuticals. It came as a bit of a shock...

Read more

Scientists reveal plan to target the cause of Alzheimer’s disease

27 September 2018

Scientists reveal plan to target the cause of Alzheimer’s disease Researchers have developed a new way to target the toxic particles that destroy healthy brain cells in Alzheimer’s disease. This is the first time that a systematic method to go after the pathogens – the cause of Alzheimer’s disease - has been proposed -...

Read more


New research facility for neurodegenerative disorders opened in Cambridge

27 September 2018

The Chemistry of Health building, a new facility dedicated to the use of chemical techniques to combat disease, in particular neurodegenerative disorders such as Alzheimer’s and Parkinson’s diseases, was officially opened today in Cambridge. The building houses the Centre for Misfolding Diseases, a world-leading research...

Read more

Bereavement triggers development of low-cost AI heart monitor

18 September 2018

A Cambridge startup has developed a low-cost next-generation wearable heart and cardiovascular function monitor which uses AI to diagnose heart rhythm and respiratory problems in real time. Cambridge Heartwear hopes to use its wireless monitor to improve detection of irregular and dangerous heart rhythms and reduce the...

Read more


Implantable device stops seizures at the first signs of an episode

10 September 2018

Implantable Device Stops Seizures at the First Signs of an Episode A new device from researchers at the University of Cambridge, École Nationale Supérieure des Mines and French National Institute of Health and Medical Research (INSERM) in France can stop seizures at the first symptom. So far researchers have implanted the...

Read more

Protein discovery may explain why some patients develop resistance to new class of anti-cancer drugs

26 July 2018

A team of researchers at the University of Cambridge has identified a protein complex that might explain why some cancer patients treated with the revolutionary new anti-cancer drugs known as PARP inhibitors develop resistance to their medication. As we improve our understanding of these DNA repair networks and how they...

Read more


Making sense of cancer’s ‘big data’ problem to revolutionise patient care

12 July 2018

A new institute at the University of Cambridge aims to revolutionise cancer care by using cutting edge analytics to maximize the use of big data sets collected from patients. Integrated cancer medicine offers the promise of turning the tsunami of data generated in medical practice into an extraordinarily powerful but...

Read more

Cambridge partners with industry leaders to fund research on global sustainability challenges

12 July 2018

The Prince of Wales Global Sustainability Fellowship Programme represents a multi-million-pound commitment from the private sector to accelerate progress on UN Sustainable Development Goals. The Prince of Wales Global Sustainability Fellowship Programme will create a rich intellectual space for collaboration between...

Read more


WT Developing Concept Fund and MRC Confidence in Concept fund

WT Developing Concept Fund and MRC Confidence in Concept fund CATS and OTR invite you to submit applications for internal pump-priming funding for biomedical translational research. The MRC Confidence in Concept fund is intended to accelerate the transition from discovery research to translational development projects by...

Read more

Cambridge and Nokia Bell Labs establish new research center to advance AI-supported multi-sensory personal devices

21 June 2018

The long-sought dream of wearable and mobile devices that will interpret, replicate and influence people’s emotions and perceptions will soon be a reality thanks to a collaboration between the University and Nokia Bell Labs. Nokia Bell Labs is a founding partner of the new Centre for Mobile, Wearable Systems and Augmented...

Read more


New 3D imaging analysis technique could lead to improved arthritis treatment

18 June 2018

An algorithm to monitor the joints of patients with arthritis, which could change the way that the severity of the condition is assessed, has been developed by a team of engineers, physicians and radiologists led by the University of Cambridge. Using this technique, we’ll hopefully be able to identify osteoarthritis...

Read more

Rosalind Franklin Institute to harness disruptive technology to transform drug discovery

8 June 2018

Business Secretary Greg Clark today announced funding for a series of ambitious technology projects that will transform the way medicines are discovered, enabling the pharmaceutical industry to develop groundbreaking drugs faster, cheaper and better than ever before. Our partnership in the institute gives us access to, and...

Read more


Biomedical Industry Engagement Fund (apply by 2nd July 2018)

Applications are invited for flexible ‘Biomedical Industry Engagement Fund’ awarded to the University by the BBSRC 1 and MRC 2 to support innovative academic-industry interactions. These funds are available to University researchers working within the remit of the BBSRC and MRC for exchange of personnel, perspectives and...

Read more

Six months of Herceptin could be as effective as 12 months for some women with early-stage breast cancer

18 May 2018

For women with HER2 positive early-stage breast cancer taking Herceptin for six months could be as effective as 12 months in preventing relapse and death, and can reduce side effects, finds new research. We are confident that this will mark the first steps towards a reduction of Herceptin treatment to six months in many...

Read more


Professor Lynn Gladden named Executive Chair of Engineering and Physical Sciences Research Council

8 May 2018

Professor Lynn Gladden CBE, FRS, FREng has been selected to be the next Executive Chair of the Engineering and Physical Sciences Research Council (EPSRC), as announced today by Science Minister Sam Gyimah. She will take up the role in October, succeeding Professor Philip Nelson who will step down at the end of September...

Read more

The body in miniature

21 March 2018

The Body in Miniature The past few years has seen an explosion in the number of studies using organoids – so-called ‘mini organs’. While they can help scientists understand human biology and disease, some in the field have questioned their usefulness. But as the field matures, we could see their increasing use in...

Read more


Development of optoacoustic imaging for breast cancer detection advanced by collaboration with Munich-based small company

In 2015, Professor Fiona Gilbert, Honorary Consultant Radiologist with Addenbrooke’s Hospital and Professor of Radiology at Cambridge University's School of Clinical Medicine, successfully applied for a grant from our Research Exchange scheme to carry out collaborative work with iThera Medical, a Munich-based spin out...

Read more

Industry Experts in Residence

Our Industry Experts in Residence are available to University of Cambridge staff for: Advice on the applicability of specific ideas to drug discovery, diagnostics & devices Advice on translational grant applications Discussions about progression of current translational research projects Work in conjunction with...

Read more


Latest news

“Placental organoids” could be the future of pregnancy and conception research say researchers

5 December 2018

“Placental organoids” could be the future of pregnancy and conception research say researchers Researchers have successfully managed to develop “mini placentas” or placenta organoids in the laboratories that could transform research of pregnancy, conception, stillbirth, miscarriages and pregnancy diseases and disorders...

AI system may accelerate search for cancer discoveries

29 November 2018

AI system may accelerate search for cancer discoveries Searching through the mountains of published cancer research could be made easier for scientists, thanks to a new AI system. The system, called LION LBD and developed by computer scientists and cancer researchers at the University of Cambridge, has been designed to...

Microsoft to support AI research at Cambridge University

5 November 2018

The University of Cambridge is teaming up with Microsoft to tackle the problem of 'brain drain' in AI and machine learning research. The software giant will help increase AI research capacity and capability at Cambridge by supporting visiting researchers, postdoctoral researchers, PhD students and interns from the UK, EU...